Medicines : Very important drug shortages might develop into extra possible when the UK quits the European Union, MPs are warning after well being ministers had been unable to present ensures on how they’d stop fallout from a ”no deal” Brexit.
A report by the Public Accounts Committee (PAC) on medicines shortages final 12 months discovered no proof that the federal government was adequately ready for comparable disruption from leaving the EU.
The report mentioned it was “worrying” that the Division “couldn’t guarantee us of its plans to safeguard the provision of medicines after the UK has exited the European Union”.
Unexpected increases in the prices of certain generic drugs cost the NHS hundreds of millions of pounds last year and despite signs in June 2017 and the government was “slow to take action to manage the financial impact”, the report said.
Meg Hillier, chairwoman of the committee, said increases in prices of generics last year “should have served as a wake-up call” for Government.
She said: “While the Department of Health and Social Care now has new powers at its disposal, it could not explain to us how these will better enable it to handle similar price increases and related shortages in future.
“This is unacceptable and doubly worrying in the context of uncertainty over supply chains after Brexit, particularly for medicines with a short shelf-life.
“Government cannot afford to drag its feet on this critical issue, either now or after Brexit. By the end of this year we expect it to demonstrate it has a clear plan to ensure patients can access the medicines they need, and to mitigate the impact of price rises on desperately stretched NHS resources.”
A Department of Health and Social Care spokesperson said: “The Government is confident of reaching a deal with the EU that benefits patients and the NHS is preparing for all situations.
So what do you think?
Tell us in the comments.